Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 142

1.

Balancing access and innovation: India's Supreme Court rules on imatinib.

Rajkumar R, Kesselheim AS.

JAMA. 2013 Jul 17;310(3):263-4. doi: 10.1001/jama.2013.7336. No abstract available.

PMID:
23824051
[PubMed - indexed for MEDLINE]
2.

Novartis challenges India's drug patent laws in Supreme Court.

Billingsley M.

BMJ. 2012 Feb 21;344:e1279. doi: 10.1136/bmj.e1279. No abstract available.

PMID:
22354594
[PubMed - indexed for MEDLINE]
3.

Patent dispute: Delhi High Court gives a boost to access to affordable medicines.

Menghaney L.

Indian J Med Ethics. 2010 Apr-Jun;7(2):97-100.

PMID:
20432882
[PubMed - indexed for MEDLINE]
4.

The impact of TRIPS on innovation and exports: a case study of the pharmaceutical industry in India.

Malhotra P.

Indian J Med Ethics. 2008 Apr-Jun;5(2):61-5.

PMID:
18624153
[PubMed - indexed for MEDLINE]
5.

Intellectual property. Challenges to India's pharmaceutical patent laws.

Sampat BN, Shadlen KC, Amin TM.

Science. 2012 Jul 27;337(6093):414-5. doi: 10.1126/science.1224892. Epub 2012 Jul 5. No abstract available.

PMID:
22767892
[PubMed - indexed for MEDLINE]
6.

"To patent or not to patent? the case of Novartis' cancer drug Glivec in India".

Gabble R, Kohler JC.

Global Health. 2014 Jan 6;10:3. doi: 10.1186/1744-8603-10-3.

PMID:
24393270
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Impact of India's new patents law 2005: a physician's perspective.

Lele RD.

J Assoc Physicians India. 2005 Aug;53:671-5. No abstract available.

PMID:
16398073
[PubMed - indexed for MEDLINE]
8.

Comment: compulsory licensing of patented pharmaceutical inventions: evaluating the options.

Reichman JH.

J Law Med Ethics. 2009 Summer;37(2):247-63. doi: 10.1111/j.1748-720X.2009.00369.x.

PMID:
19493070
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Supreme Court of India rejects Novartis’ cancer drug patent.

Heseltine P.

Pharm Pat Anal. 2013 May;2(3):299-300. doi: 10.4155/ppa.13.28. No abstract available.

PMID:
24237056
[PubMed - indexed for MEDLINE]
Free Article
10.

Access to medicine and the dangers of patent linkage: lessons from Bayer Corp v. Union of India.

Tsui M.

J Law Med. 2011 Mar;18(3):577-88.

PMID:
21528741
[PubMed - indexed for MEDLINE]
11.

Discussions in Geneva, demonstrations in Delhi: why incentives for drug innovation need reviewing.

Ford N, 't Hoen E, von Schoen-Angerer T.

Drug Discov Today. 2007 May;12(9-10):349-51. Epub 2007 Apr 2. No abstract available.

PMID:
17467570
[PubMed - indexed for MEDLINE]
12.

India's patent ecosystem - encouraging strong patents or discouraging innovation?

Harrison C.

Nat Rev Drug Discov. 2013 Oct;12(10):732-3. doi: 10.1038/nrd4139. No abstract available.

PMID:
24080690
[PubMed - indexed for MEDLINE]
13.

India's rejection of Novartis's patent is but a small step in the right direction.

Bhaumik S.

BMJ. 2013 Apr 17;346:f2412. doi: 10.1136/bmj.f2412. No abstract available.

PMID:
23596223
[PubMed - indexed for MEDLINE]
14.

Indian biogenerics industry emerges.

Jayaraman KS.

Nat Biotechnol. 2003 Oct;21(10):1115-6. No abstract available.

PMID:
14520378
[PubMed - indexed for MEDLINE]
15.

Big nation, nano dream - the prospects of India's nanotech revolution.

Agoramoorthy G, Chakraborty C, Hsu MJ.

Drug Discov Today. 2010 Jul;15(13-14):495-8. doi: 10.1016/j.drudis.2010.03.012. Epub 2010 Apr 2. No abstract available.

PMID:
20363360
[PubMed - indexed for MEDLINE]
16.

Intellectual property. Balancing innovation and access: patent challenges tip the scales.

Higgins MJ, Graham SJ.

Science. 2009 Oct 16;326(5951):370-1. doi: 10.1126/science.1176116. No abstract available.

PMID:
19833944
[PubMed - indexed for MEDLINE]
17.

[Drug industry in India is threatened by free trade agreement].

Jeppsson A.

Lakartidningen. 2009 Oct 7-13;106(41):2589. Swedish. No abstract available.

PMID:
19927922
[PubMed - indexed for MEDLINE]
18.

India's patent laws under pressure.

Roderick P, Pollock AM.

Lancet. 2012 Sep 15;380(9846):e2-4. No abstract available.

PMID:
22988579
[PubMed - indexed for MEDLINE]
19.

Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?

Oliveira MA, Bermudez JA, Chaves GC, Velásquez G.

Bull World Health Organ. 2004 Nov;82(11):815-21. Epub 2004 Dec 14.

PMID:
15640916
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

How TRIPS benefits Indian industry and how it may not benefit the Indian people.

Srinivasan S.

Indian J Med Ethics. 2008 Apr-Jun;5(2):66-9. Review. No abstract available.

PMID:
18624154
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk